Lupin gets USFDA nod for narcolepsy drug Pitolisant
Drugmaker Lupin has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application for Pitolisant Tablets, 4.45 mg and 17.8 mg. The USFDA approved the…
